Health Catalyst, Inc. (HCAT)

Health Catalyst Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-105.54	-118.15	-137.4	-153.21	-115.02	-240.92
Depreciation & Amortization	44.76	45.21	51.53	41.11	23.03	12.67
Share-Based Compensation	52.71	55.76	72.1	65.15	37.96	17.84
Other Operating Activities	-9.16	-15.9	-21.5	23.83	27.88	-2.6
Operating Cash Flow	-17.23	-33.08	-35.27	-23.12	-26.15	-32.18
Capital Expenditures	-12.61	-13.16	-15.13	-17.07	-9.2	-2.34
Acquisitions	-11.39	-11.39	-27.85	-46.76	-101.66	0
Change in Investments	106.74	45.97	6.21	-74.47	29.54	-205.33
Other Investing Activities	-1.1	-1.12	-2.26	-1.37	-1.25	-1.94
Investing Cash Flow	81.63	20.29	-39.02	-139.68	-82.57	-209.6
Share Issuance / Repurchase	3.5	2.73	-1.27	270.37	40.54	200.28
Debt Issued / Paid	0	0	0	0	143.7	25.35
Other Financing Activities	-	-	-1.34	-6.29	-1.62	5.75
Financing Cash Flow	3.5	2.73	-2.61	264.08	182.61	231.38
Exchange Rate Effect	-0	0.02	-0.01	-0.01	0.03	0.01
Net Cash Flow	67.89	-10.04	-76.92	101.27	73.92	-10.4
Free Cash Flow	-29.85	-46.24	-50.4	-40.2	-35.35	-34.52
Free Cash Flow Margin	-10.06%	-15.63%	-18.24%	-16.61%	-18.72%	-22.28%
Free Cash Flow Per Share	-0.51	-0.82	-0.94	-0.85	-0.89	-1.84

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).